""

about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index

Barbara M. Goldsmith, PhD, FACB

 

 

Barbara M. Goldsmith, PhD, FACB

 

Professor, Pathology and Laboratory Medicine

Director, Clinical Chemistry

Email: barbara.goldsmith@tuhs.temple.edu

 

 

 

Department of Pathology and Laboratory Medicine

 

Educational Background:

 

BS, Hobart and William Smith Colleges, Geneva, NY, 1975

 

PhD, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, 1982

 

Fellow, National Academy of Clinical Biochemistry (NACB)

 

Return to top

 

 

Research Interests:

 

  • Applications of new and novel technologies to laboratory testing that provide practical and meaningful results to physicians and patients
  • Analysis of clinical laboratory data (prospective and retrospective) to provide support for appropriate interpretation and utilization

Return to top


 

CLINICAL Interests:

 
  • Improve patient care through quality laboratory testing
  • Specific areas of laboratory medicine include adult and pediatric clinical chemistry, point of care testing and quality management

Return to top

 

 

professional affiliations:

 

  • American Association for Clinical Chemistry (AACC), Past President
  • National Academy of Clinical Biochemistry (NACB), President-Elect
  • Academy of Clinical Laboratory Physicians and Scientists (ACLPS)
  • Food and Drug Administration (FDA), Clinical Chemistry and Toxicology Advisory Panel (Voting Member)
  • International Federation of Clinical Chemistry (IFCC), Committee on Laboratory Management
  • College of American Pathologists (CAP), Point of Care Testing Committee (AACC Liaison)


Return to top

 

 

PUBMED PUBLICATIONS :


Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

10882321. Lipman TH, Hayman LL, Fabian CV, DiFazio DA, Hale PM, Goldsmith BM, Piascik PC, Risk factors for cardiovascular disease in children with Type I diabetes. Nurs Res 49:3(160-6)2000 May-Jun

10383088. Christenson RH, Demers LM, Goldsmith BM, Noel SA, Duh SH, Performance characteristics of the creatine kinase-MB mass assay on the Vitros ECi analyzer. Clin Biochem 32:3(237-40)1999 Apr

10172406. Goldsmith BM, New POCT (point-of-care testing) guide establishes testing uniformity. MLO Med Lab Obs 27:8(50-2)1995 Aug

2339686. Hommes FA, Brewster MA, Burton BK, Buist NR, Elsas LJ, Goldsmith BM, Hammond J, Kruckeberg WC, Leichtman LG, Lin KT, Proficiency testing for biochemical genetics laboratories: the first 10 rounds of testing. Am J Hum Genet 46:5(1001-4)1990 May

2331830. Goldsmith BM, Campos JM, Comparison of urine dipstick, microscopy, and culture for the detection of bacteriuria in children. Clin Pediatr (Phila) 29:4(214-8)1990 Apr

3581480. Goldsmith BM, Gruemer HD, Systemic membrane defect and the inhibition of lymphocyte capping in Duchenne muscular dystrophy. Clin Chim Acta 164:1(33-46)1987 Apr 15

3100094. Goldsmith BM, Munson S, Rate nephelometry and radial immunodiffusion compared for measuring serum prealbumin. Clin Chem 33:1(161-3)1987 Jan

3581469. Goldsmith BM, Feinstein C, Munson S, Reiss A, Borengasser-Caruso MA, Determination of a reference range for whole blood serotonin in a pediatric population using high pressure liquid chromatography with electrochemical detection. Clin Biochem 19:6(359-63)1986 Dec

3968612. Reiss AL, Feinstein C, Rosenbaum KN, Borengasser-Caruso MA, Goldsmith BM, Autism associated with Williams syndrome. J Pediatr 106:2(247-9)1985 Feb

3967373. Goldsmith BM, Hicks JM, Rhabdomyolysis: two pediatric case reports. Clin Chem 31:2(314-7)1985 Feb

6374498. Goldsmith BM, Drachman DB, Gruemer HD, Miller WG, Self SS, Blind evaluation of lymphocyte capping in Duchenne muscular dystrophy. Neurology 34:6(821-4)1984 Jun

6713632. Gruemer HD, Miller WG, Chinchilli VM, Leshner RT, Hassler CR, Blasco PA, Nance WE, Goldsmith BM, Are reference limits for serum creatine kinase valid in detection of the carrier state for Duchenne muscular dystrophy? Clin Chem 30:5(724-30)1984 May

7371153. Goldsmith BM, Gruemer HD, Hawley RJ, Pickard NA, Verrill HL, Nance WE, Miller G, Crawford RG, The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait. Clin Chem 26:6(754-9)1980 May

88637. Pickard NA, Gruemer HD, Nance WE, Goldsmith BM, Lymphocyte capping in Duchenne muscular dystrophy. Lancet 2:8137(306)1979 Aug 11

5043832. Baldinger R, Goldsmith BM, Capel WC, Stewart GT, Pot smokers, junkies, and squares: a comparative study of female values. Int J Addict 7:1(153-66)1972

5009179. Capel WC, Goldsmith BM, Waddell KJ, Stewart GT, The aging narcotic addict: an increasing problem for the next decades. J Gerontol 27:1(102-6)1972 Jan

Return to top